394 related articles for article (PubMed ID: 33389490)
21. Soluble uric acid induces myocardial damage through activating the NLRP3 inflammasome.
Zhang H; Ma Y; Cao R; Wang G; Li S; Cao Y; Zhang H; Liu M; Liu G; Zhang J; Li S; Wang Y; Ma Y
J Cell Mol Med; 2020 Aug; 24(15):8849-8861. PubMed ID: 32558367
[TBL] [Abstract][Full Text] [Related]
22. Research progress on related mechanisms of uric acid activating NLRP3 inflammasome in chronic kidney disease.
Wang M; Lin X; Yang X; Yang Y
Ren Fail; 2022 Dec; 44(1):615-624. PubMed ID: 35382689
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-22 ameliorated renal injury and fibrosis in diabetic nephropathy through inhibition of NLRP3 inflammasome activation.
Wang S; Li Y; Fan J; Zhang X; Luan J; Bian Q; Ding T; Wang Y; Wang Z; Song P; Cui D; Mei X; Ju D
Cell Death Dis; 2017 Jul; 8(7):e2937. PubMed ID: 28726774
[TBL] [Abstract][Full Text] [Related]
24. Nuciferine restores potassium oxonate-induced hyperuricemia and kidney inflammation in mice.
Wang MX; Liu YL; Yang Y; Zhang DM; Kong LD
Eur J Pharmacol; 2015 Jan; 747():59-70. PubMed ID: 25499818
[TBL] [Abstract][Full Text] [Related]
25. Sweet Taste Receptors Mediated ROS-NLRP3 Inflammasome Signaling Activation: Implications for Diabetic Nephropathy.
Zhou L; Huang W; Xu Y; Gao C; Zhang T; Guo M; Liu Y; Ding J; Qin L; Xu Z; Long Y; Xu Y
J Diabetes Res; 2018; 2018():7078214. PubMed ID: 29675433
[TBL] [Abstract][Full Text] [Related]
26. Sarsasapogenin alleviates diabetic nephropathy through suppression of chronic inflammation by down-regulating PAR-1: In vivo and in vitro study.
Tang ZZ; Zhang YM; Zheng T; Huang TT; Ma TF; Liu YW
Phytomedicine; 2020 Nov; 78():153314. PubMed ID: 32882582
[TBL] [Abstract][Full Text] [Related]
27. [Molecular regulative mechanisms of NLRP3 inflammasome activation in diabetic nephropathy and interventional effects of Chinese herbal medicine].
Wang WW; Han WB; Wan YG; Tu Y; Liu BH; Liu YL; Wu W; Yee HY; Fang QJ; Yao J
Zhongguo Zhong Yao Za Zhi; 2020 Jan; 45(1):7-13. PubMed ID: 32237405
[TBL] [Abstract][Full Text] [Related]
28. Negative regulators and their mechanisms in NLRP3 inflammasome activation and signaling.
Kim JK; Jin HS; Suh HW; Jo EK
Immunol Cell Biol; 2017 Aug; 95(7):584-592. PubMed ID: 28356568
[TBL] [Abstract][Full Text] [Related]
29. Elevated Uric Acid Levels Promote Vascular Smooth Muscle Cells (VSMC) Proliferation via an Nod-Like Receptor Protein 3 (NLRP3)-Inflammasome-Dependent Mechanism.
Li H; Qian F; Liu H; Zhang Z
Med Sci Monit; 2019 Nov; 25():8457-8464. PubMed ID: 31707403
[TBL] [Abstract][Full Text] [Related]
30. Allopurinol, quercetin and rutin ameliorate renal NLRP3 inflammasome activation and lipid accumulation in fructose-fed rats.
Hu QH; Zhang X; Pan Y; Li YC; Kong LD
Biochem Pharmacol; 2012 Jul; 84(1):113-25. PubMed ID: 22426011
[TBL] [Abstract][Full Text] [Related]
31. Targeting NLRP3 inflammasome as a promising approach for treatment of diabetic nephropathy: Preclinical evidences with therapeutic approaches.
Ram C; Jha AK; Ghosh A; Gairola S; Syed AM; Murty US; Naidu VGM; Sahu BD
Eur J Pharmacol; 2020 Oct; 885():173503. PubMed ID: 32858047
[TBL] [Abstract][Full Text] [Related]
32. Optineurin inhibits NLRP3 inflammasome activation by enhancing mitophagy of renal tubular cells in diabetic nephropathy.
Chen K; Feng L; Hu W; Chen J; Wang X; Wang L; He Y
FASEB J; 2019 Mar; 33(3):4571-4585. PubMed ID: 30571313
[TBL] [Abstract][Full Text] [Related]
33. Monosodium Urate Crystals Activate the Inflammasome in Primary Progressive Multiple Sclerosis.
Piancone F; Saresella M; Marventano I; La Rosa F; Santangelo MA; Caputo D; Mendozzi L; Rovaris M; Clerici M
Front Immunol; 2018; 9():983. PubMed ID: 29780394
[TBL] [Abstract][Full Text] [Related]
34. The purinergic 2X7 receptor participates in renal inflammation and injury induced by high-fat diet: possible role of NLRP3 inflammasome activation.
Solini A; Menini S; Rossi C; Ricci C; Santini E; Blasetti Fantauzzi C; Iacobini C; Pugliese G
J Pathol; 2013 Nov; 231(3):342-53. PubMed ID: 23843215
[TBL] [Abstract][Full Text] [Related]
35. Overnutrition-induced gout: An immune response to NLRP3 inflammasome dysregulation by XOD activity increased in quail.
Wu H; Wang Y; Ren Z; Li Y; Huang J; Lin Z; Zhang B
Front Immunol; 2022; 13():1074867. PubMed ID: 36569836
[TBL] [Abstract][Full Text] [Related]
36. Metabolic Dysfunction in the Regulation of the NLRP3 Inflammasome Activation: A Potential Target for Diabetic Nephropathy.
Zhao W; Zhou L; Novák P; Shi X; Lin CB; Zhu X; Yin K
J Diabetes Res; 2022; 2022():2193768. PubMed ID: 35719709
[TBL] [Abstract][Full Text] [Related]
37. NLRP3 Inflammasome: A central player in renal pathologies and nephropathy.
Henedak NT; El-Abhar HS; Soubh AA; Abdallah DM
Life Sci; 2024 Aug; 351():122813. PubMed ID: 38857655
[TBL] [Abstract][Full Text] [Related]
38. Shizhifang ameliorates pyroptosis of renal tubular epithelial cells in hyperuricemia through inhibiting NLRP3 inflammasome.
Zhou J; Wang C; Zhang X; Wu Z; Wu Y; Li D; Gao J
J Ethnopharmacol; 2023 Dec; 317():116777. PubMed ID: 37311502
[TBL] [Abstract][Full Text] [Related]
39. The Overexpression of Sirtuin1 (SIRT1) Alleviated Lipopolysaccharide (LPS)-Induced Acute Kidney Injury (AKI) via Inhibiting the Activation of Nucleotide-Binding Oligomerization Domain-Like Receptors (NLR) Family Pyrin Domain Containing 3 (NLRP3) Inflammasome.
Gao Q; Zhu H
Med Sci Monit; 2019 Apr; 25():2718-2726. PubMed ID: 30980521
[TBL] [Abstract][Full Text] [Related]
40. Combined SGLT2 and DPP4 Inhibition Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Nephropathy in Mice with Type 2 Diabetes.
Birnbaum Y; Bajaj M; Yang HC; Ye Y
Cardiovasc Drugs Ther; 2018 Apr; 32(2):135-145. PubMed ID: 29508169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
